Calcineurin inhibitor withdrawal and replacement with sirolimus in cardiac transplant recipients with renal dysfunction.

被引:0
|
作者
Kushwaha, SS [1 ]
Wilson, JA [1 ]
Frantz, RP [1 ]
Rodeheffer, RJ [1 ]
Clavell, AL [1 ]
Daly, RC [1 ]
McGregor, CG [1 ]
Edwards, BS [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
056
引用
收藏
页码:170 / 170
页数:1
相关论文
共 50 条
  • [31] Calcineurin inhibitor substitution with sirolimus vs. reduced-dose calcineurin inhibitor plus sirolimus is associated with improved renal dysfunction in heart transplant patients
    Potter, Brian J.
    Giannetti, Nadia
    Edwardes, Michael D. deB.
    Cecere, Renzo
    Cantarovich, Marcelo
    [J]. CLINICAL TRANSPLANTATION, 2007, 21 (03) : 305 - 308
  • [32] Studies on effects of calcineurin inhibitor withdrawal on arterial distensibility and endothelial function in renal transplant recipients
    Kosch, M
    Hausberg, M
    Suwelack, B
    [J]. TRANSPLANTATION, 2003, 76 (10) : 1516 - 1519
  • [33] Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low dose calcineurin inhibitors
    Dubay, Derek
    Lilly, Leslie
    Smith, Robert
    Levy, Gory A.
    Therapondos, George
    [J]. HEPATOLOGY, 2007, 46 (04) : 495A - 495A
  • [34] Steroid or tacrolimus withdrawal in renal transplant recipients using sirolimus
    de Sandes Freitas, Taina Veras
    Harada, Kelly Miyuki
    Felipe, Claudia Rosso
    Galante, Nelson Zocoler
    Mandia Sampaio, Edison Luiz
    Ikehara, Edson
    Alfieri, Fernando
    Tedesco-Silva Junior, Helio
    Medina-Pestana, Jose Osmar
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (04) : 1221 - 1228
  • [35] Steroid or tacrolimus withdrawal in renal transplant recipients using sirolimus
    Tainá Veras de Sandes Freitas
    Kelly Miyuki Harada
    Cláudia Rosso Felipe
    Nelson Zocoler Galante
    Edison Luiz Mandia Sampaio
    Edson Ikehara
    Fernando Alfieri
    Hélio Tedesco-Silva Júnior
    José Osmar Medina-Pestana
    [J]. International Urology and Nephrology, 2011, 43 : 1221 - 1228
  • [36] Observation of efficacy and safety of converting the calcineurin inhibitor to sirolimus in renal transplant recipients with chronic allograft nephropathy
    Chen, J.
    Li, L.
    Wen, J.
    Tang, Z.
    Ji, S.
    Sha, G.
    Cheng, Z.
    Sun, Q.
    Cheng, D.
    Liu, Z.
    [J]. TRANSPLANTATION PROCEEDINGS, 2008, 40 (05) : 1411 - 1415
  • [37] Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients
    Chinnock, Timothy J.
    Shankel, Tamara
    Deming, Douglas
    Cutler, Drew
    Sahney, Shobha
    Fitts, James
    Chinnock, Richard E.
    [J]. PEDIATRIC TRANSPLANTATION, 2011, 15 (07) : 746 - 749
  • [38] Conversion from calcineurin inhibitors to sirolimus improves renal function in heart transplant recipients with de novo renal dysfunction
    El-Hamamsy, I.
    Stevens, L. M.
    White, M.
    Perrault, L. P.
    Pellerin, M.
    Carrier, M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S120 - S121
  • [39] Calcineurin (CNI) withdrawal in liver transplant (LTx) recipients with late renal dysfunction - A viable and worthwhile option
    Humar, A
    Horn, K
    Kalis, A
    Glessing, B
    Gruessner, A
    Gruessner, R
    Kandaswamy, R
    Payne, WD
    Lake, JR
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 363 - 363
  • [40] The significance of luminex testing in renal transplant recipients with allograft dysfunction.
    Qazi, Yasir A.
    Cicciarelli, James
    Hermes, Mark
    Smogorzewski, Miroslaxv
    Koss, Michael
    Sher, Linda
    Selby, Robert R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 355 - 355